Treatment of the Carotid In-stent Restenosis: A Systematic Review

Conclusions: rCAS is the most common treatment for ISR, with low postoperative risk and low long-term risk. CEA is an important alternative for rCAS. PTA may be less recommended due to the relatively high long-term risks of stroke & TIA and recurrent restenosis.
Source: Frontiers in Neurology - Category: Neurology Source Type: research